FAQs
About Delta-Fly Pharma
Q.
When was the company established?
A.
The company was founded on December 6, 2010, in Tokushima.
Q.
When was the company listed?
A.
The company was listed on Mothers of the Tokyo Stock Exchange on October 12, 2018.
Q.
What is the origin of the company name?
A.
The company name is derived from Dragonfly. Dragonflies represent an unflagging spirit to advance as they only go forward, and do not go backward.
Q.
What is your company business?
A.
We are a bio venture company that develops gentle anticancer drugs using our concept of Module Drug Development.
Q.
What is Module Drug Development?
A.
Module Drug Development is the assembly of various active ingredients into novel anticancer agents. With this approach and application of drug delivery technologies and knowledge about dosage and administration, drugs with a good balance of safety and efficacy can be developed in a short period of time.